188 related articles for article (PubMed ID: 22179996)
1. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
Yuan H; Niu YM; Wang RX; Li HZ; Chen N
Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
[TBL] [Abstract][Full Text] [Related]
2. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
4. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.
Lin H; Lin D; Zheng C
Diagn Pathol; 2014 Jan; 9():15. PubMed ID: 24443924
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
[TBL] [Abstract][Full Text] [Related]
6. XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
Cui J; Li D; Shen L; Zhang W; Xu X
Tumour Biol; 2014 Jul; 35(7):6335-41. PubMed ID: 24652592
[TBL] [Abstract][Full Text] [Related]
7. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
[TBL] [Abstract][Full Text] [Related]
8. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
Ding DP; Ma WL; He XF; Zhang Y
Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
10. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.
Wang M; Gu D; Zhang Z; Zhou J; Zhang Z
J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231
[TBL] [Abstract][Full Text] [Related]
11. [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis].
Wu XB; Dai LP; Wang YP; Wang KJ; Zhang JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):281-5. PubMed ID: 19642387
[TBL] [Abstract][Full Text] [Related]
12. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.
Guo XF; Wang J; Lei XF; Zeng YP; Dong WG
Intern Med; 2015; 54(3):251-9. PubMed ID: 25748732
[TBL] [Abstract][Full Text] [Related]
13. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
14. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.
McCarty KM; Smith TJ; Zhou W; Gonzalez E; Quamruzzaman Q; Rahman M; Mahiuddin G; Ryan L; Su L; Christiani DC
Carcinogenesis; 2007 Aug; 28(8):1697-702. PubMed ID: 17470448
[TBL] [Abstract][Full Text] [Related]
16. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.
Zhu HL; Bao JM; Lin PX; Li WX; Zou ZN; Huang YE; Chen Q; Shen H
Asian Pac J Cancer Prev; 2014; 15(16):6619-25. PubMed ID: 25169498
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
18. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
19. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
